Abstract
In this issue of Blood, Fazi and colleagues have asked important questions and added several new observations to our understanding of monoclonal B-cell lymphocytosis(MBL) in its role as the precursor state of chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have